Literature DB >> 21926381

Seroepidemiology of the newly found trichodysplasia spinulosa-associated polyomavirus.

Tingting Chen1, Petri S Mattila, Tuomas Jartti, Olli Ruuskanen, Maria Söderlund-Venermo, Klaus Hedman.   

Abstract

Trichodysplasia spinulosa (TS)-associated polyomavirus (TSV) was recently (in 2010) discovered in TS lesions. To investigate the seroprevalence and primary exposure time of this virus, we set up a virus protein (VP1) viruslike particle (VLP)-based immunoglobulin G enzyme immunoassay. The seroprevalence of TSV was 5%, among children aged 1-4 years, rising to 48% at 6-10 years, and 70% among 149 adults. The TSV antibodies did not cross-react with corresponding Merkel cell polyomavirus VLPs, and their reactivity appeared conformational. TSV circulates widely in the human population and primary exposure is extensive in childhood, beginning at age 1-2 years.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21926381     DOI: 10.1093/infdis/jir614

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  24 in total

1.  Seroprevalence of human Malawi polyomavirus.

Authors:  Jérôme T J Nicol; Valérie Leblond; Françoise Arnold; Giovanni Guerra; Elisa Mazzoni; Mauro Tognon; Pierre Coursaget; Antoine Touzé
Journal:  J Clin Microbiol       Date:  2013-10-30       Impact factor: 5.948

2.  Development and Evaluation of a Broad Bead-Based Multiplex Immunoassay To Measure IgG Seroreactivity against Human Polyomaviruses.

Authors:  Hans L Zaaijer; Mariet C W Feltkamp; Sergio Kamminga; Els van der Meijden; Herman F Wunderink; Antoine Touzé
Journal:  J Clin Microbiol       Date:  2018-03-26       Impact factor: 5.948

3.  Prospective Study of Human Polyomaviruses and Risk of Cutaneous Squamous Cell Carcinoma in the United States.

Authors:  Anala Gossai; Tim Waterboer; Heather H Nelson; Jennifer A Doherty; Angelika Michel; Martina Willhauck-Fleckenstein; Shohreh F Farzan; Brock C Christensen; Anne G Hoen; Ann E Perry; Michael Pawlita; Margaret R Karagas
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-02-11       Impact factor: 4.254

4.  ALTERNATIVE METHODS FOR SEQUENCING FULL TSPyV GENOMES USING SANGER OR NGS.

Authors:  Paulo Roberto Urbano; Ana Carolina Soares de Oliveira; Camila Malta Romano
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2016-12-08       Impact factor: 1.846

Review 5.  The Biology and Clinical Features of Cutaneous Polyomaviruses.

Authors:  Khang D Nguyen; Bahir H Chamseddin; Clay J Cockerell; Richard C Wang
Journal:  J Invest Dermatol       Date:  2018-11-22       Impact factor: 8.551

Review 6.  [Human polyomavirus-associated skin diseases].

Authors:  Steffi Silling; Alexander Kreuter; Ulrike Wieland
Journal:  Hautarzt       Date:  2022-04-28       Impact factor: 0.751

7.  Detection of trichodysplasia spinulosa-associated polyomavirus in a fatal case of myocarditis in a seven-month-old girl.

Authors:  Shinya Tsuzuki; Hitomi Fukumoto; Sohtaro Mine; Noriko Sato; Makoto Mochizuki; Hideki Hasegawa; Tsuyoshi Sekizuka; Makoto Kuroda; Takeji Matsushita; Harutaka Katano
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

8.  Seroepidemiology of Human Polyomaviruses in a US Population.

Authors:  Anala Gossai; Tim Waterboer; Heather H Nelson; Angelika Michel; Martina Willhauck-Fleckenstein; Shohreh F Farzan; Anne G Hoen; Brock C Christensen; Karl T Kelsey; Carmen J Marsit; Michael Pawlita; Margaret R Karagas
Journal:  Am J Epidemiol       Date:  2015-12-13       Impact factor: 4.897

9.  Age-specific seroprevalences of merkel cell polyomavirus, human polyomaviruses 6, 7, and 9, and trichodysplasia spinulosa-associated polyomavirus.

Authors:  Jérôme T J Nicol; Rémy Robinot; Audrey Carpentier; Giovanni Carandina; Elisa Mazzoni; Mauro Tognon; Antoine Touzé; Pierre Coursaget
Journal:  Clin Vaccine Immunol       Date:  2013-01-09

10.  Trichodysplasia spinulosa-associated polyomavirus (TSV) and Merkel cell polyomavirus: correlation between humoral and cellular immunity stronger with TSV.

Authors:  Arun Kumar; Anu Kantele; Tommi Järvinen; Tingting Chen; Heli Kavola; Mohammadreza Sadeghi; Klaus Hedman; Rauli Franssila
Journal:  PLoS One       Date:  2012-09-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.